POLR2A and cancer: In particular, as the most potent inhibitor of cellular transcription, α-amanitin targets the unique vulnerability of cancer cells conferred by genomic loss of POLR2A and 17p, which significantly increases therapeutic index by selectively killing cancer cells with this genomic aberrancy, and accordingly reduces potential in vivo toxicity.